1- (1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3 daahirnimo>98.0% (HPLC) Brexpiprazole Warshada Dhexe
Ruifu Kiimikada Dhexdhexaadinta Brexpiprazole
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1- (1-Benzothiophen-4-yl) Piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy) quinolin-2(1H) -hal CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3
Magaca Kiimikada | 1- (1-Benzothiophen-4-yl) Piperazine Hydrochloride |
La mid ah | Brexpiprazole Dhexdhexaadiyaha 2;1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;1-Benzo[b]thien-4-ylpiperazine Monohydrochloride |
Lambarka CAS | 913614-18-3 |
Lambarka CAT | RF-PI1034 |
Heerka Saamiyada | Kaydka dhexdiisa, Awoodda Wax-soo-saarka 100MT/Sannadka |
Qaanuunka molecular | C12H15ClN2S |
Miisaanka Molecular | 254.7789 |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Caddaan ilaa budo cad-cad |
Aqoonsiga | Waqtiga haynta ee muunadku waxa uu waafaqsan yahay heerka tixraaca |
Daahirnimada / Habka Falanqaynta | >99.0% (HPLC) |
Khasaare xagga qalajinta | <0.50% |
Biyaha (KF) | <0.50% |
Hadhaaga dabka | <0.20% |
Walxaha laxidhiidha | (HPLC) |
Xumaan Shaqsiyeed Kasta | <0.50% |
Wadarta wasakhda | <1.00% |
Infrared Spectrum | Waafaqsan Qaab-dhismeedka |
Proton NMR Spectrum | Waafaqsan Qaab-dhismeedka |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyaha Brexpiprazole (CAS: 913611-97-9) |
Xidhmada: Dhalo, bacda bireed aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka
1- (1-Benzothiophen-4-yl) piperazine Hydrochloride (CAS: 913614-18-3) waa dhexdhexaadka Brexpiprazole (CAS: 913611-97-9).Brexpiprazole waa nooc ka mid ah antipsychotic aan caadi ahayn.Waa dopamine D2 receptor qayb agonist ah.Sida modulator-ka firfircoon ee serotonin-dopamine, waxaa loo isticmaali karaa daawaynta schizophrenia, iyo daaweynta isku dhafan ee niyad-jabka.Waxa kale oo ay ku siin kartaa waxtar iyo dulqaad ku saabsan daawaynta isku dhafan ee la aasaasay ee xanuunka niyad-jabka (MDD).Daroogadu waxay soo bandhigaysaa astaan farmaajo gaar ah, oo u shaqeysa sidii qayb ka mid ah agonist ee serotonin 5-HT1A iyo dopamine D2 reseptors iyo sida antagonist buuxa ee 5-HT2A iyo noradrenaline α1B / 2C reseptors, oo leh isku xirnaanta subnanomolar isku mid ah.Daawada, oo ay sameeyeen Otsuka iyo Lundbeck, ayaa 2015 FDA u oggolaatay daawaynta schizophrenia iyo sida daaweynta isku dhafan ee niyad-jabka.